Literature DB >> 7745749

Brain- and intestine-specific variants of reovirus serotype 3 strain dearing are selected during chronic infection of severe combined immunodeficient mice.

B L Haller1, M L Barkon, X Y Li, W M Hu, J D Wetzel, T S Dermody, H W Virgin.   

Abstract

Mutants of mammalian reoviruses, enteric double-stranded-RNA-containing viruses that spread systemically after primary replication in intestinal tissue, have been extensively studied as models of viral pathogenesis. While reovirus serotype 3 strain Dearing (T3D) causes acute encephalitis in newborn mice, adult severe combined immunodeficient (SCID) mice develop chronic infection with T3D, with some mice living more than 100 days after infection (B. L. Haller, M. L. Barkon, G. P. Vogler, and H. W. Virgin IV, J. Virol. 69:357-364, 1995). To determine whether organ-specific reovirus variants are selected during chronic infection, we characterized the pathogenetic properties of two variants of T3D isolated 87 days after intraperitoneal infection of adult SCID mice. A brain-specific variant (T3DvBr) (i) grew to a higher titer than T3D in SCID mouse brain (but not intestine) after intraperitoneal inoculation, (ii) killed adult SCID mice faster than T3D, and (iii) grew well in neonatal NIH Swiss [NIH(s)] mouse brain tissue after intramuscular but not peroral inoculation. An intestine-specific variant (T3DvInt) (i) grew to a higher titer than T3D in SCID mouse intestine (but not brain) after intraperitoneal inoculation, (ii) killed SCID mice with kinetics equivalent to those of T3D, (iii) was much less virulent than T3D in neonatal NIH(s) mice, (iv) grew better than T3D in intestines after intramuscular or peroral inoculation into neonatal NIH(s) mice, and (v) grew poorly in brain tissue of neonatal NIH(s) mice after intramuscular inoculation. During prolonged infection of SCID mice, organ-specific variants of T3D, which are more efficient than wild-type T3D at one specific stage in reovirus pathogenesis, are selected.

Entities:  

Mesh:

Year:  1995        PMID: 7745749      PMCID: PMC189121          DOI: 10.1128/JVI.69.6.3933-3937.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Passive immunity modulates genetic reassortment between rotaviruses in mixedly infected mice.

Authors:  J L Gombold; R F Ramig
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

2.  Distinct pathways of viral spread in the host determined by reovirus S1 gene segment.

Authors:  K L Tyler; D A McPhee; B N Fields
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

3.  Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing).

Authors:  K M Kaye; D R Spriggs; R Bassel-Duby; B N Fields; K L Tyler
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

4.  Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes.

Authors:  D K Bodkin; B N Fields
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).

Authors:  H W Virgin; R Bassel-Duby; B N Fields; K L Tyler
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle.

Authors:  L J Sturzenbecker; M Nibert; D Furlong; B N Fields
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

7.  Persistent rotavirus infection in mice with severe combined immunodeficiency.

Authors:  M Riepenhoff-Talty; T Dharakul; E Kowalski; S Michalak; P L Ogra
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination.

Authors:  M R Lieber; J E Hesse; S Lewis; G C Bosma; N Rosenberg; K Mizuuchi; M J Bosma; M Gellert
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

9.  Organ-specific selection of viral variants during chronic infection.

Authors:  R Ahmed; M B Oldstone
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system.

Authors:  K L Tyler; H W Virgin; R Bassel-Duby; B N Fields
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  3 in total

1.  In Vivo Live Imaging of Oncolytic Mammalian Orthoreovirus Expressing NanoLuc Luciferase in Tumor Xenograft Mice.

Authors:  Yuta Kanai; Takahiro Kawagishi; Yoshiharu Matsuura; Takeshi Kobayashi
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

2.  Cleavage susceptibility of reovirus attachment protein sigma1 during proteolytic disassembly of virions is determined by a sequence polymorphism in the sigma1 neck.

Authors:  J D Chappell; E S Barton; T H Smith; G S Baer; D T Duong; M L Nibert; T S Dermody
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Oncolytic virotherapy for multiple myeloma: past, present, and future.

Authors:  Chandini M Thirukkumaran; Don G Morris
Journal:  Bone Marrow Res       Date:  2011-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.